NanoMedSyn develops innovative glycovectors and nanovectors for drug targeting in close collaborations with national and international health research institutes. The research and innovation are supported by the Occitanie region, Montpellier Metropole and the national research agencies, DREETS, ANR, ANRT and Bpifrance. Partnerships are in progress with companies involved in the development of immunotherapies using antibodies.

Photo credit: